MK-2461

Alias: MK 2461; MK-2461; MK2461
Cat No.:V0575 Purity: ≥98%
MK-2461 (MK2461) is a novel,potent, ATP-competitive, multi-targeted inhibitor for c-Met (WT/mutants) with potential antineoplastic activity.
MK-2461 Chemical Structure CAS No.: 917879-39-1
Product category: PDGFR
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
2mg
5mg
10mg
25mg
50mg
100mg
250mg
Other Sizes
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text

 

  • Business Relationship with 5000+ Clients Globally
  • Major Universities, Research Institutions, Biotech & Pharma
  • Citations by Top Journals: Nature, Cell, Science, etc.
Top Publications Citing lnvivochem Products
Purity & Quality Control Documentation

Purity: ≥98%

Product Description

MK-2461 (MK2461) is a novel, potent, ATP-competitive, multi-targeted inhibitor for c-Met (WT/mutants) with potential antineoplastic activity. With an IC50 of 0.4-2.5 nM, it inhibits a range of c-Met mutants and has a lower potency against kinases like Ron and Flt1. When it comes to inhibiting c-Met, MK-2461 is 8–30 times more selective than FGFR1, FGFR2, FGFR3, PDGFRβ, KDR, Flt3, Flt4, TrkA, and TrkB. NK MK-2461 efficiently inhibited autophosphorylation of the c-Met activation loop while suppressing constitutive or ligand-induced phosphorylation of the juxtamembrane domain and COOH-terminal docking site of c-Met, as well as its downstream signaling to the phosphoinositide 3-kinase–AKT and Ras–extracellular signal-regulated kinase pathways in tumor cells.

Biological Activity I Assay Protocols (From Reference)
Targets
c-Met(M1250T) (IC50 = 0.4 nM); c-Met(Y1235D) (IC50 = 0.5 nM); c-Met(Y1230H) (IC50 = 1.0 nM); c-Met(N1100) (IC50 = 1.5 nM); c-Met(Y1230C) (IC50 = 1.5 nM)
ln Vitro
MK-2461 additionally has IC50 values of 65 nM, 39 nM, 50 nM, 44 nM, 46 nM, 61 nM, and 78 nM for FGFR1, FGFR2, FGFR3, KDR, TrkA, TrkB, and Flt4, respectively. With IC50 values of 1.5 nM, 1.5 nM, 1.0 nM, 0.5 nM, and 0.4 nM, respectively, MK-2461 more effectively suppresses the activity of oncogenic c-Met kinase mutants, including N1100Y, Y1230C, Y1230H, Y1235D, and M1250T, in comparison to wild-type c-Met. Phosphorylated c-Met is more strongly bound by MK-2461 than unphosphorylated c-Met. MK-2461 effectively prevents ATP from causing the c-Met'sCOOH-terminaldocking domain to become autophosphorylated, but not the activation loop. On the other hand, MK-2461 has an IC50 of less than 0.3 μM and prevents phosphorylation of PDGFRα (Y849) in H1703 cells and the activation loop of FGFR2 (Y653/Y654) in Kato III cells. MK-2461 inhibits HGF-induced branching tubulogenesis of MDCK cells, HGF-induced migration of HPAF II cells (IC50 of 404 nM), and HGF-induced mitogenesis of 4MBr-5 cells (IC50 of 204 nM). Furthermore, with an IC50 of approximately 100 nM, MK-2461 effectively suppresses the IL-3-independent proliferation of 32D cells transformed with Tpr-Met or Tpr-Met (Y362C) mutant. A wide panel of tumor cell lines is considerably inhibited in growth by MK-2461, which is particularly effective against tumor cells that have MET or FGFR2 genomic amplification.[1]
ln Vivo
MK-2461 treatment, with an IC50 of approximately 1 μM, significantly inhibits the phosphorylation of c-Met (Y1349) in GTL-16 tumors. MK-2461 can effectively suppress the growth of GTL-16 xenograft tumors in mice by 62%, 77%, 75%, and 90% when given orally at doses of 10 mg/kg, 50 mg/kg, 100 mg/kg, and 200 mg/kg once daily. The growth of NIH3T3 tumors containing the c-Met single nucleotide mutants T3936C and T3997C is similarly inhibited by MK-2461 treatment at 134 mg/kg twice daily, by 78% and 62%, respectively.[1]
Enzyme Assay
EQEDEPEGDYFEWLE-CONH2 phosphorylation is measured by means of a time-resolved fluorescence resonance energy transfer assay. This phosphorylation is catalyzed by c-Met. In [2] Timing-resolved fluorescence resonance energy transfer assays, akin to the c-Met kinase assay, are used to determine the MK-2461 IC50 for Ron, Mer, Flt1, Flt3, Flt4, KDR, PDGFRβ, FGFR1, FGFR2, FGFR3, TrkA, and TrkB.
Cell Assay
For 72 hours, cells are exposed to different MK-2461 concentrations. The ViaLight PLUS kit is used to measure the viability of tumor cells.
Animal Protocol
Female nude CD-1 nu/nu mice inoculated s.c. with GTL-16 cells or c-Met mutant-transformed NIH3T3 cells
~134 mg/kg
Orally once or twice daily
References
[1]. Cancer Res . 2010 Feb 15;70(4):1524-33.

[2]. Anal Biochem . 1999 Apr 10;269(1):94-104.

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C24H25N5O5S
Molecular Weight
495.55
Exact Mass
495.16
Elemental Analysis
C, 58.17; H, 5.09; N, 14.13; O, 16.14; S, 6.47
CAS #
917879-39-1
Appearance
Solid powder
SMILES
CN1C=C(C=N1)C2=CC3=C(C=CC4=C(C3=O)C=C(C=C4)NS(=O)(=O)N(C)C[C@@H]5COCCO5)N=C2
InChi Key
JGEBLDKNWBUGRZ-HXUWFJFHSA-N
InChi Code
InChI=1S/C24H25N5O5S/c1-28-13-18(12-26-28)17-9-22-23(25-11-17)6-4-16-3-5-19(10-21(16)24(22)30)27-35(31,32)29(2)14-20-15-33-7-8-34-20/h3-6,9-13,20,27H,7-8,14-15H2,1-2H3/t20-/m1/s1
Chemical Name
14-[[[(2R)-1,4-dioxan-2-yl]methyl-methylsulfamoyl]amino]-5-(1-methylpyrazol-4-yl)-2-oxo-7-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaene
Synonyms
MK 2461; MK-2461; MK2461
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
DMSO: ~99 mg/mL (~199.8 mM)
Water: <1 mg/mL
Ethanol: <1 mg/mL
Solubility (In Vivo)
1% DMSO+30% polyethylene glycol+1% Tween 80, pH 4: 15mg/mL
 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.0180 mL 10.0898 mL 20.1796 mL
5 mM 0.4036 mL 2.0180 mL 4.0359 mL
10 mM 0.2018 mL 1.0090 mL 2.0180 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration mg/mL;

Method for preparing DMSO stock solution mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation:Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Clinical Trial Information
NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT00496353 Completed Drug: MK2461 Neoplasm Merck Sharp & Dohme LLC June 2007 Phase 1
Phase 2
NCT00518739 Completed Drug: MK2461 Advanced Cancer Merck Sharp & Dohme LLC February 2007 Phase 1
Biological Data
  • MK-2461

    Differential effects of MK-2461 on phosphorylation of key tyrosine residues of c-Met. Cancer Res. 2010 Feb 15;70(4):1524-33.

  • MK-2461

    MK-2461 effectively inhibited phosphorylation of the activation loop of FGFR2 and PDGFR in cells. Cancer Res. 2010 Feb 15;70(4):1524-33.

  • MK-2461

    Orally administered MK-2461 inhibited c-Met phosphorylation and xenograft tumor growth in nude mice. Cancer Res. 2010 Feb 15;70(4):1524-33.

Contact Us